Activist investor ups pressure on Lamb Weston as french fry maker reaches ‘critical juncture’

Starboard said the food company has failed to restore investor confidence and show that it’s on a path toward “sustainable” growth.

Activist investor ups pressure on Lamb Weston as french fry maker reaches ‘critical juncture’
Courtesy of Lamb Weston · Source: Food Dive

Food Dive reported the development on 2026-05-06. Starboard said the food company has failed to restore investor confidence and show that it’s on a path toward “sustainable” growth.

The report places the news in a wider commercial context. French fry maker Lamb Weston is at a “critical juncture” and needs to take steps to “rebuild” support from shareholders after a series of missteps by prior management, activist investor Starboard warned the company’s board in a letter.

For the food sector, the practical implications extend beyond the immediate announcement. “At this Investor Day, the Company must first reestablish the foundation of its story: Lamb Weston is a high-quality business with a leadership position within an attractive industry,” Starboard wrote in its April 30 letter.

Attention now turns to how companies, customers and regulators respond. Lamb Weston is no stranger to pressure from activist investors. It reached a separate agreement with Jana Partners last summer that gave the firm a larger presence on the company’s board through the appointment of former food industry executives from Nestlé USA and McCormick & Co.

Original source

Food Dive

https://www.fooddive.com/news/activist-investor-ups-pressure-on-lamb-weston-as-french-fry-maker-reaches/819434/

This report is prepared from the public source listed above for news and industry-information purposes. Original research, text, trademarks and images remain with their authors and rights holders; open material is used under the licence identified by its source. Rights holders may contact rights@asiafoodtimes.com with evidence of ownership, and verified concerns will be corrected or removed promptly. This article is not investment, legal, medical or nutrition advice.